Early Access Programs – What to Consider as a Patient

Early Access Programs allow patients and physicians to use investigational (pre-approval) drugs outside the clinical trial setting. They are often referred to as Expanded Access Programs (EAPs), Compassionate Use Programs (CUPs), or Managed Access [...]

By |2023-04-13T11:10:15+01:00October 7th, 2021|Blog|

Who is in charge of granting pre-approval drug access?

Patients suffering from rare diseases or life-threatening illnesses, like cancer, can often find that there are very few treatment options available to them. For these patients, accessing an investigational drug outside of the clinical trial [...]

By |2023-04-13T11:13:36+01:00July 4th, 2018|Blog|
Go to Top